About 2 results found for searched term "Labetuzumab" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24697 | Labetuzumab govitecan | Drug-Linker Conjugates for ADC |
| IMMU 130 hMN-14-SN-38 | ||
| Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer. | ||
| M24980 | Labetuzumab | Others |
| Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
